Shashank J. Patel

5.3k total citations · 2 hit papers
20 papers, 1.4k citations indexed

About

Shashank J. Patel is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Shashank J. Patel has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Shashank J. Patel's work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and T-cell and B-cell Immunology (5 papers). Shashank J. Patel is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and T-cell and B-cell Immunology (5 papers). Shashank J. Patel collaborates with scholars based in United States, United Kingdom and Qatar. Shashank J. Patel's co-authors include Nicholas P. Restifo, Madhusudhanan Sukumar, Douglas C. Palmer, Robert Eil, Christopher A. Klebanoff, Rahul Roychoudhuri, Tori N. Yamamoto, Suman K. Vodnala, Zhiya Yu and Jenny H. Pan and has published in prestigious journals such as Nature, Science and The Journal of Experimental Medicine.

In The Last Decade

Shashank J. Patel

19 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ionic immune suppression within the tumour microenvironment limits T cell effector function

2016 489 citations Robert Eil, Suman K. Vodnala et al. Nature profile →
T cell stemness and dysfunction in tumors are triggered by a common mechanism

2019 409 citations Suman K. Vodnala, Robert Eil et al. Science profile →

Peers

Countries citing papers authored by Shashank J. Patel

Since Specialization

Citations

This map shows the geographic impact of Shashank J. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashank J. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashank J. Patel more than expected).

Fields of papers citing papers by Shashank J. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashank J. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashank J. Patel. The network helps show where Shashank J. Patel may publish in the future.

Co-authorship network of co-authors of Shashank J. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Shashank J. Patel. A scholar is included among the top collaborators of Shashank J. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashank J. Patel. Shashank J. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The FLRT3-UNC5B checkpoint pathway inhibits T cell–based cancer immunotherapies 2024 ·Science Advances ·(unknown), Chuan Yan, Qiqi Yang, (unknown), Daniel P. Fitzgerald, (unknown), Jahangheer Shaik, (unknown), K. Myers, (unknown), (unknown), (unknown), (unknown), Zachary Cusumano, Solomon Langermann, David M. Langenau, Shashank J. Patel, Dallas B. Flies	1
2	Agronomic Zn Biofortification of Cereal Crops a Sustainable Way to Ensuring Nutritional Security: A Review 2023 ·International Journal of Environment and Climate Change ·(unknown), (unknown), Priyanka Saha, Himanshu Tiwari, (unknown), (unknown), Shashank J. Patel, (unknown)	3
3	Summarization and Simplification of Medical Articles using Natural Language Processing 2022 ·2022 13th International Conference on Computing Communication and Networking Technologies (ICCCNT) ·Shashank J. Patel, (unknown), (unknown), Sudhir Dhage	3
4	A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells 2021 ·Blood ·Linjie Tian, (unknown), Rustin R. Lovewell, (unknown), Junshik Hong, (unknown), Kwang Woon Kim, (unknown), (unknown), Shashank J. Patel, Linda N. Liu, (unknown), Solomon Langermann, Dallas B. Flies, Tae Kon Kim	1
5	Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies 2020 ·Cancer Cell ·Devikala Gurusamy, Amanda N. Henning, Tori N. Yamamoto, Zhiya Yu, Nikolaos Zacharakis, Sri Krishna, Rigel J. Kishton, Suman K. Vodnala, (unknown), Li Jia, (unknown), Mary A. Black, Robert Eil, Douglas C. Palmer, Jenny H. Pan, Madhusudhanan Sukumar, Shashank J. Patel, Nicholas P. Restifo	116
6	Outcomes of patients with melanoma brain metastases (MBM) treated with standard of care therapy after being excluded from MBM-specific clinical trials 2019 ·Annals of Oncology ·(unknown), Michael Shephard, Lauren E. Haydu, (unknown), Rodabe N. Amaria, Shashank J. Patel, Adi Diab, (unknown), (unknown), (unknown), Eric Burton, M. A. Davies, Hussein A. Tawbi	1
7	T cell stemness and dysfunction in tumors are triggered by a common mechanism breakdown → 2019 ·Science ·Suman K. Vodnala, Robert Eil, Rigel J. Kishton, Madhusudhanan Sukumar, Tori N. Yamamoto, (unknown), Ping‐Hsien Lee, (unknown), Shashank J. Patel, Zhiya Yu, Douglas C. Palmer, Michael J. Kruhlak, Xiaojing Liu, Jason W. Locasale, Jing Huang, Rahul Roychoudhuri, Toren Finkel, Christopher A. Klebanoff, Nicholas P. Restifo	409
8	Ionic immune suppression within the tumour microenvironment limits T cell effector function breakdown → 2016 ·Nature ·Robert Eil, Suman K. Vodnala, David Clever, Christopher A. Klebanoff, Madhusudhanan Sukumar, Jenny H. Pan, Douglas C. Palmer, Alena Gros, Tori N. Yamamoto, Shashank J. Patel, Geoffrey Guittard, Zhiya Yu, Valentina Carbonaro, Klaus Okkenhaug, David S. Schrump, W. Marston Linehan, Rahul Roychoudhuri, Nicholas P. Restifo	489
9	Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance 2015 ·The Journal of Experimental Medicine ·Douglas C. Palmer, Geoffrey Guittard, Zulmarie Franco, Joseph G. Crompton, Robert Eil, Shashank J. Patel, Yun Ji, Nicholas van Panhuys, Christopher A. Klebanoff, Madhusudhanan Sukumar, David Clever, Anna Chichura, Rahul Roychoudhuri, Rajat Varma, Ena Wang, Luca Gattinoni, Francesco M. Marincola, Lakshmi Balagopalan, Lawrence E. Samelson, Nicholas P. Restifo	139
10	Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape 2015 ·Cellular and Molecular Immunology ·Joseph G. Crompton, Manikandan Narayanan, Suresh Cuddapah, Rahul Roychoudhuri, Yun Ji, Wenjing Yang, Shashank J. Patel, Madhusudhanan Sukumar, Douglas C. Palmer, Weiqun Peng, Ena Wang, Francesco M. Marincola, Christopher A. Klebanoff, Keji Zhao, John S. Tsang, Luca Gattinoni, Nicholas P. Restifo	86
11	GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes 2015 ·Clinical & Experimental Metastasis ·(unknown), Kendra A. Williams, Ying Hu, Jonathan Andreas, Shashank J. Patel, Suiyuan Zhang, Nigel P.S. Crawford	43
12	Modulating immunometabolism of tumor specific mouse and human lymphocytes to enhance T cell based therapy for cancer 2015 ·Journal for ImmunoTherapy of Cancer ·Madhusudhanan Sukumar, Jie Liu, Shashank J. Patel, Christopher A. Klebanoff, Gautam U. Mehta, Rahul Roychoudhuri, Joseph G. Crompton, David Clever, Luca Gattinoni, Pawel Muranski, Toren Finkel, Nicholas P. Restifo	1
13	Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape 2015 ·Cellular and Molecular Immunology ·Joseph G. Crompton, Manikandan Narayanan, Suresh Cuddapah, Rahul Roychoudhuri, Yun Ji, Wenjing Yang, Shashank J. Patel, Madhusudhanan Sukumar, Douglas C. Palmer, Weiqun Peng, Ena Wang, Francesco M. Marincola, Christopher A. Klebanoff, Keji Zhao, John S. Tsang, Luca Gattinoni, Nicholas P. Restifo	8
14	Elevated potassium levels suppress T cell activation within tumors 2015 ·Journal for ImmunoTherapy of Cancer ·Robert Eil, Rahul Roychoudhuri, David Clever, Shashank J. Patel, (unknown), Jenny H. Pan, Douglas C. Palmer, Christopher A. Klebanoff, Nicholas P. Restifo	2
15	Cish actively silences tcr signaling in CD8+ T cells to maintain tumor tolerance 2015 ·Journal for ImmunoTherapy of Cancer ·Douglas C. Palmer, Geoffrey Guittard, Zulmarie Franco, Shashank J. Patel, Christopher A. Klebanoff, Madhusudhanan Sukumar, Robert Eil, David Clever, Lakshmi Balagopalan, Rahul Roychoudhuri, (unknown), Nicholas P. Restifo	0
16	A Systems Genetics Approach Identifies CXCL14, ITGAX, and LPCAT2 as Novel Aggressive Prostate Cancer Susceptibility Genes 2014 ·PLoS Genetics ·Kendra A. Williams, (unknown), Ying Hu, Jonathan Andreas, Shashank J. Patel, Suiyuan Zhang, Peter S. Chines, Abdel Elkahloun, Settara C. Chandrasekharappa, J. Silvio Gutkind, Alfredo Molinolo, Nigel P.S. Crawford	61
17	Metastasis-Associated Protein Ribosomal RNA Processing 1 Homolog B (RRP1B) Modulates Metastasis through Regulation of Histone Methylation 2014 ·Molecular Cancer Research ·(unknown), Amy M. Dworkin, Jens Lichtenberg, Shashank J. Patel, Niraj Trivedi, Derek Gildea, David M. Bodine, Nigel P.S. Crawford	14
18	Cish attenuates proximal TCR-signaling and CD8+ T cell immunity 2014 ·Journal for ImmunoTherapy of Cancer ·Douglas C. Palmer, Geoffrey Guittard, Shashank J. Patel, Lawrence E. Samelson, Nicholas P. Restifo	1
19	Germline Genetic Variation Modulates Tumor Progression and Metastasis in a Mouse Model of Neuroendocrine Prostate Carcinoma 2013 ·PLoS ONE ·Shashank J. Patel, Alfredo Molinolo, J. Silvio Gutkind, Nigel P.S. Crawford	22
20	Single-dose, Two-way Crossover, Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects 2011 ·Clinical Therapeutics ·Shashank J. Patel, Vijay S. Chauhan, (unknown), Samir Shah, Keyur Patel, (unknown), (unknown), (unknown), Prashant Kale, Kamlesh D. Patel, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact